Yet Fetuin-A levels are strongly influenced by hepatic fat accumulation, obesity, and systemic inflammation, complicating clinical interpretation and suggesting that Fetuin-A may function more as a marker of metabolic dysfunction than a direct causal mediator [50,52,53]. The gene discussed is AHSG; the disease is obesity due to melanocortin 4 receptor deficiency.